Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Mesothelioma, Malignant 2Hearing Loss 2Testicular Neoplasms 1Seminoma 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Optic Nerve Glioma 1Oligodendroglioma 1Necrosis 1Mesothelioma 1Medulloblastoma 1Gastrointestinal Neoplasms 1Familial ependymoma 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Astrocytoma 1Appendiceal Neoplasms 1

Interventions

sodium thiosulfate 2ebselen 1Sodium Chloride 1Saline Solution 1Ringer's Lactate 1Platinum 1Ofloxacin 1Magnetic Resonance Spectroscopy 1Hyaluronic Acid 1Hearing 1Cisplatin 1Acetylcysteine 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Hearing Loss × sodium thiosulfate × Clear all
NCT07218913 2026-04-17

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

City of Hope Medical Center

Phase 1 Recruiting
44 enrolled
Genitourinary

Testicular Neoplasms, Seminoma, Hearing Loss

NCT04262336 2023-07-06

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Decibel Therapeutics

Phase 1 Completed
22 enrolled

Ototoxicity, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡